Attention Laurel Patients:  The new Laurel office is open. The address is 7140 Contee Road, Suite 3500, Laurel, MD 20707….Attention Lanham Patients: Our new Largo office will be opening Monday,  June 17th and our Lanham location will be closed permanently. Largo’s address is 9333 Healthcare Way Suite 4100 Largo, MD 20774.

Trial Protocol ID USOR 22198_FURMO-004 *STAR* & *RIT*

Trial Description

A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • ArriVent BioPharma, Inc.

ClinicalTrials.gov NCT ID

  • NCT05607550